Kate C. Agopsowicz
Edmonton, AB T6G2E1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Erratum: Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment.
Journal: Molecular therapy. Oncology
Published: April 10, 2024
Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment.
Journal: Molecular therapy oncolytics
Published: June 29, 2023
Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model.
Journal: Cancer letters
Published: January 26, 2023
Procaspase-Activating Compound-1 Synergizes with TRAIL to Induce Apoptosis in Established Granulosa Cell Tumor Cell Line (KGN) and Explanted Patient Granulosa Cell Tumor Cells In Vitro.
Journal: International journal of molecular sciences
Published: March 10, 2021
Inhibition of triple negative breast cancer metastasis and invasiveness by novel drugs that target epithelial to mesenchymal transition.
Journal: Scientific reports
Published: December 11, 2020
Traceable PEO-poly(ester) micelles for breast cancer targeting: The effect of core structure and targeting peptide on micellar tumor accumulation.
Journal: Biomaterials
Published: June 10, 2017
Novel High-throughput Approach for Purification of Infectious Virions.
Journal: Scientific reports
Published: June 15, 2016
Breast cancer gene therapy using an adenovirus encoding human IL-2 under control of mammaglobin promoter/enhancer sequences.
Journal: Cancer gene therapy
Published: February 10, 2016
HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.
Journal: Cancer gene therapy
Published: October 27, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026